Correction to the number of shares in the first paragraph
Upon Completion of the 10-Q Quarterly Interim Review filing, Cytta Corp will be Current and Will Regain OTCQB Status
Read More
The live podcast event for thousands of fans returns Saturday, September 6th for an unforgettable night of hoops, culture, comedy, and music. Featuring Eli Manning, Ben Stiller, and more notable guests, plus a live musical performance by Ferg.
Tickets On-Sale This Friday 10:00AM ET
Read MoreIcotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor
Filing based on unprecedented data package that met all primary endpoints across four Phase 3 studies, including head-to-head superiority comparisons versus deucravacitinib and evaluation of difficult to treat skin sites
Submission underscores potential to offer moderate-to-severe plaque psoriasis patients the standout combination of complete skin clearance, favorable safety profile, and simplicity of a once-daily pill
Read More
Preliminary evaluation confirms low-cost pathway to production
HIGHLIGHTS
Capital cost for full reinstatement of Central Gawler Mill to original design basis (600ktpa fresh ore) estimated at only ~A$26m (±30%); processing cost estimated at only A$44.50/t
Significant cost advantages versus building a new mill, or utilising third party toll milling
Targeting feasibility by end of 2025 to support initial ‘Stage 1' operations by end of 2026; early conversations underway for low-dilution credit and working capital financing
As thousands suffer without access to FDA-approved cannabis treatments, MMJ BioPharma Cultivation is waging a David vs. Goliath legal war against the DEA's decade-long deception-and incoming Administrator Terrance Cole must decide whether to continue the cover-up or finally put patients over politics.
Read More
In a bold move that bridges the worlds of high-stakes poker and high-impact social innovation, AngelAi partnered with Michael "The Grinder" Mizrachi, who had a historic victory at the 2025 World Series of Poker (WSOP) Main Event on Wednesday, where he claimed the coveted World title, a $10 million prize and entry into the hall of fame.
Read More
News Release Highlights:
Battery X Metals Inc.'s wholly-owned subsidiary, Battery X Rebalancing Technologies Inc., has entered into a Commercial Revenue Share Agreement with an arm's length, independent Vancouver-based automotive service center specializing in out-of-warranty Tesla vehicles. The agreement marks the first commercial deployment of its patent-pending, second-generation lithium-ion battery rebalancing machine ("Prototype 2.0") in a live customer-facing environment.
Under the terms of the Agreement, Battery X Rebalancing Technologies will receive 20% of gross service revenue per rebalancing procedure, plus applicable taxes, with no direct costs incurred for labor, overhead, or shop operations-establishing a potential early-stage revenue stream with no direct operating expenses.
The Revenue Share Agreement follows a successful real-world performance trial in which Prototype 2.0 restored a severely imbalanced light-duty electric truck's estimated driving range from approximately 40 kilometers to 295 kilometers-a 255-kilometer increase representing a 637.5% improvement-validating the commercial potential of the platform.
